INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Clinical trial NCT02977780 · RECRUITING
Trial details
- NCT number
- NCT02977780
- Sponsor
- David Reardon, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-09
- Primary completion
- 2028-02-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.